1. Home
  2. HOWL vs KOPN Comparison

HOWL vs KOPN Comparison

Compare HOWL & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOWL
  • KOPN
  • Stock Information
  • Founded
  • HOWL 2017
  • KOPN 1984
  • Country
  • HOWL United States
  • KOPN United States
  • Employees
  • HOWL N/A
  • KOPN N/A
  • Industry
  • HOWL Biotechnology: Pharmaceutical Preparations
  • KOPN Semiconductors
  • Sector
  • HOWL Health Care
  • KOPN Technology
  • Exchange
  • HOWL Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • HOWL 87.4M
  • KOPN 282.1M
  • IPO Year
  • HOWL 2021
  • KOPN 1992
  • Fundamental
  • Price
  • HOWL $1.45
  • KOPN $1.62
  • Analyst Decision
  • HOWL Strong Buy
  • KOPN Strong Buy
  • Analyst Count
  • HOWL 2
  • KOPN 4
  • Target Price
  • HOWL $9.50
  • KOPN $2.63
  • AVG Volume (30 Days)
  • HOWL 260.1K
  • KOPN 11.1M
  • Earning Date
  • HOWL 03-06-2025
  • KOPN 03-13-2025
  • Dividend Yield
  • HOWL N/A
  • KOPN N/A
  • EPS Growth
  • HOWL N/A
  • KOPN N/A
  • EPS
  • HOWL N/A
  • KOPN N/A
  • Revenue
  • HOWL $3,386,000.00
  • KOPN $44,266,305.00
  • Revenue This Year
  • HOWL N/A
  • KOPN $21.20
  • Revenue Next Year
  • HOWL $34.17
  • KOPN $13.55
  • P/E Ratio
  • HOWL N/A
  • KOPN N/A
  • Revenue Growth
  • HOWL N/A
  • KOPN 0.60
  • 52 Week Low
  • HOWL $1.26
  • KOPN $0.56
  • 52 Week High
  • HOWL $8.19
  • KOPN $2.77
  • Technical
  • Relative Strength Index (RSI)
  • HOWL 50.05
  • KOPN 49.22
  • Support Level
  • HOWL $1.28
  • KOPN $1.58
  • Resistance Level
  • HOWL $1.60
  • KOPN $1.94
  • Average True Range (ATR)
  • HOWL 0.11
  • KOPN 0.17
  • MACD
  • HOWL 0.03
  • KOPN -0.04
  • Stochastic Oscillator
  • HOWL 55.88
  • KOPN 19.15

About HOWL Werewolf Therapeutics Inc.

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: